Skip to content

Insider · CIK 0001296764

Richard S Serbin

director

Files at CODX (Co-Diagnostics, Inc.). First filing -, latest -.

In brief

Richard S Serbin files SEC Form 4 as director at CODX (Co-Diagnostics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Richard S Serbin has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 11 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 23, 2026CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+1,695$0.00$010,751May 27, 2026
May 23, 2026CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-1,695$0.00$04,000May 27, 2026
Nov 23, 2025CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+57,499$0.00$0271,666Nov 24, 2025
Nov 23, 2025CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-57,499$0.00$0170,834Nov 24, 2025
Aug 13, 2025CODX
Co-Diagnostics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+125,000$0.00$0228,333Aug 15, 2025
May 23, 2025CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+48,334$0.00$0214,167May 27, 2025
May 23, 2025CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-48,334$0.00$0103,333May 27, 2025
Nov 23, 2024CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+48,333$0.00$0165,833Nov 25, 2024
Nov 23, 2024CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-48,333$0.00$0151,667Nov 25, 2024
Nov 23, 2023CODX
Co-Diagnostics, Inc.
AGrant or award
Common Stock
+30,000$0.00$087,500Nov 27, 2023
Nov 23, 2023CODX
Co-Diagnostics, Inc.
MOption exercise
Restricted Stock Unitderivative
-30,000$0.00$0120,000Nov 27, 2023

Questions about Richard S Serbin

Answered from the filings on this page, as of the latest one.

Is Richard S Serbin buying or selling?

Richard S Serbin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Richard S Serbin's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard S Serbin has 0.

Where does Richard S Serbin file Form 4?

Richard S Serbin has filed Form 4 at CODX (Co-Diagnostics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Richard S Serbin: insider trades and track record | InsiderTell